InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,219.90
(
-0.03%
)
US TECH 100
17,738.20
(
0.08%
)
Dow Jones
39,381.87
(
-0.13%
)
Brent Oil
82.12
(
-1.31%
)
Bitcoin
61,431.85
(
-2.34%
)
Post# of 1367
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

midastouch017

Send PM Follow Ignore
Followers 145
Posts 27567
Boards Moderated 3
Alias Born 02/07/2004

midastouch017

Re: None

Wednesday, 07/27/2016 11:25:42 AM

Wednesday, July 27, 2016 11:25:42 AM

Post# of 1367
Gamida Cell Announces First Patient with Sickle Cell Disease Transplanted in Phase 1/2 Study of CordIn™ as the Sole Graft Source
CordIn has the potential to be a sole graft source for rare genetic diseases where transplantation is the only clinically established cure

#msg-124144482
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up